Vasopressin in pediatric shock and cardiac arrest

Pediatric Critical Care Medicine

Volumn 9, Issue 4, 2008, Pages 372-379

  Choong, Karen ^a   Kissoon, Niranjan ^b  

^a MCMASTER CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiac arrest; Child; Inotrope; Septic shock; Shock; Vasopressin

Indexed keywords

ADRENALIN; TERLIPRESSIN; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ADULT; BLOOD PRESSURE; CAPILLARY FLOW; CARDIOGENIC SHOCK; CHILD; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DRUG EFFECT; DRUG SAFETY; HEART ARREST; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; ISCHEMIA; LOW DRUG DOSE; MYOCARDIAL DISEASE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PERFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SIDE EFFECT; SKIN DEFECT; TACHYCARDIA; VASOPRESSIN RELEASE; WEANING; WOUND COMPLICATION; ANIMAL; CRITICAL ILLNESS; METABOLISM; METHODOLOGY; PHYSIOLOGY; SHOCK;

ANIMALS; CARDIOPULMONARY RESUSCITATION; CHILD; CLINICAL TRIALS AS TOPIC; CRITICAL ILLNESS; HEART ARREST; HUMANS; SHOCK; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 59849098875     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e318172d7c8     Document Type: Review

References (94)

1. Watson RS, Carcillo JA, Walter T, et al.: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701.
2. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588-595.
3. Mullner M, Urbanek B, Havel C, et al.: Vasopressors for shock. Cochrane Database Syst Rev 2004; CD003709.
4. Farand P, Hamel M, Lauzier F, et al.: Review article: Organ perfusion/permeability-related effects of norepinephrine and vasopressin in sepsis. Can J Anesth 2006; 53:934-946.
5. McNamara PJ: Too much of a good thing? Epinephrine on trial! J Perinatol 2005; 25: 223-224.
6. Oliver GS, Schäfer EA: On the physiological action of extracts of pituitary body and certain other glandular organs. J Physiol (Lond) 1895; 18:277-279.
7. Carcillo JA, Fields AI: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30:1365-1378.
8. Mutlu GM, Factor P: Role of vasopressin in the management of septic shock. Intensive Care Med 2004; 30:1276-1291.
9. Russell JA: Vasopressin in vasodilatory and septic shock. Curr Opin Crit Care 2007; 13: 383-391.
10. Velden RVD: Die Nierenwirkung con Hypophysenextrakten beim Menschen. Berl Klin Wochenschr 1913; 50:2083-2086.
11. Du Vigneaud V, Gish DT, Katsoyannis P: A synthetic preparation possessing biological properties associated with arginine-vasopressin. J Am Chem Soc 1954; 76:4751-4752.
12. Treshcan TA, Peters J: The vasopressin system: Physiology and clinical strategies. Anesthesiology 2006; 105:599-612.
13. Holmes CL, Landry DW, Granton JT: Science review: Vasopressin and the cardiovascular system part 1-Receptor physiology. Crit Care 2003; 7:427-434.
14. Forrest P: Vasopressin and Shock. Anaesth Intensive Care 2001; 29:463-472.
15. Dünser MW, Wenzel V, Mayr AJ, et al.: Management of vasodilatory shock: Defining the role of arginine vasopressin. Drugs 2003; 63: 237-256.
16. Shrier R, Berl T, Anderson R: Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979; 236:F321-F332.
17. Oliver JA, Landry DW: Endogenous and exogenous vasopressin in shock. Curr Opin Crit Care 2007; 13:376-382.
18. Hirsch A, Majzoub J, Ren C, et al.: Contribution of vasopressin to blood pressure regulation during hypovolemic hypotension in humans. J Appl Phyisiol 1993; 75:1984-1988.
19. Kasting N, Mazurek M, Martin J: Endotoxin increases vasopressin release independently of known physiological stimuli. Am J Physiol 1985; 248:E420-E424.
20. Chikanza I, Petrou P, Chrousos G: Perturbations of arginine vasopressin secretion during inflammatory stress: Pathophysiologic implications. Ann NY Acad Sci 2000; 917: 825-834.
21. Gerigk M, Gnehm H, Rascher W: Arginine vasopressin and renin in acutely ill children: Implication for fluid therapy. Acta Paediatr 1996; 85:550-553.
22. Neville K, Verge C, O'Meara M, et al.: High antidiuretic hormone levels and hyponatremia in children with gastroenteritis. Pediatrics 2005; 116:1401-1407.
23. Landry DW, Levin HR, Gallant EM, et al.: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125.
24. Sharshar T, Blanchard A, Paillard M, et al.: Circulating vasopressin levels in septic shock. Crit Care Med 2003; 31:1752-1758.
25. Tsuneyoshi I, Yamada H, Kakihana Y, et al.: Hemodynamic and metabolic effects of lowdose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487-493.
26. Sharshar T, Carlier R, Blanchard A, et al.: Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002; 30:497-500.
27. Robin JK, Oliver JA, Landry DW: Vasopressin deficiency in the syndrome of irreversible shock. J Trauma 2003; 54:S149-S154.
28. Ertmer C, Bone H-G, Morelli A, et al.: Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia. Shock 2007; 27:281-288. (Pubitemid 46272456)
29. Choi SJ, Jefferies HE, Wills BC, et al.: Vasopressin deficiency in pediatric septic shock. Pediatr Crit Care Med 2003; 4:S141.
30. Rosenzweig EB, Starc TJ, Chen JM, et al.: Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100:II182-II186.
31. Leclerc F, Walter-Nicolet E, Leteurtre S, et al.: Admission plasma vasopressin levels in children with meningococcal septic shock. Intensive Care Med 2003; 29:1339-1344.
32. Lodha R, Vivekanandhan S, Sarthi M, et al.: Serial circulating vasopressin levels in children with septic shock. Pediatr Crit Care Med 2006; 7:220-224.
33. Carcillo JA, Pollack MM, Ruttimann UE, et al.: Sequential physiologic interactions in pediatric cardiogenic and septic shock. Crit Care Med 1989; 17:12-16.
34. Ceneviva G, Paschall JA, Maffei F, et al.: Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102:e19.
35. Müller B, Morgenthaler N, Stolz D, et al.: Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007; 37:145-152.
36. Morgenthaler N, Müller B, Struck J, et al.: Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007; 28: 219-226.
37. Voelckel WG, Wenzel V, Lindner KH: Is one drug enough? Arginine vasopressin in pediatric cardiopulmonary resuscitation. Resuscitation 2002; 52:157-158.
38. Argenziano M, Choudhri AF, Oz MC, et al.: A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96:SII286-SII290.
39. Dünser MW, Mayr AJ, Ulmer H, et al.: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-2319.
40. Malay MB, Ashton RC Jr, Landry DW, et al.: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47: 699-703.
41. Patel BM, Chittock DR, Russell JA, et al.: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582.
42. Chen JM, Cullinane S, Spanier TB, et al.: Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100:II244 -II246.
43. Holmes CL, Landry DW, Granton JT: Science review: Vasopressin and the cardiovascular system part 2-Clinical physiology. Crit Care 2004; 8:15-23.
44. Mohring J, Glanzer K, Maciel JA, et al.: Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol 1980; 2:3677-13376.
45. Thiemermann C, Szabo C, Mitchell JA, et al.: Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 1993; 90: 267-271.
46. Bartelstone HJ, Nasmyth PA: Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol 1965; 208:754-762.
47. Dubois MJ, De Backer D, Creteur J, et al.: Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Intensive Care Med 2003; 29:1020-1023.
48. Malay MB, Ashton JL, Dahl K, et al.: Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med 2004; 32:1327-1331.
49. Sun Q, Dimopoulos G, Nguyen DN, et al.: Low-dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003; 168:481-486.
50. Edwards RM, Trizna W, Kinter LB: Renal microvascular effects of vasopressin and vasopressin antagonists. Abstr. Am J Physiol 1989; 256:F274-F278.
51. Bilezikjian LM, Vale WW: Regulation of ACTH secretion from corticotrophs: The interaction of vasopressin and CRF. Ann NY Acad Sci 1987; 512:85-96.
52. Annane D: Corticosteroids for septic shock. Crit Care Med 2001; 29:S117-S120.
53. Buijk SE, Bruining HA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1998; 98:187.
54. Dünser MW, Hasibeder WR, Wenzel V, et al.: Endocrinologic response to vasopressin infusion in advanced vasodilatory shock. Crit Care Med 2004; 32:1266-1271. (Pubitemid 38738577)
55. Russell JA: Hemodynamic support of sepsis. Vasopressin versus norepinephrine for septic shock. In: Program and Abstracts of the Society of Critical Care Medicine 36th Critical Care Congress, February 17-21, 2007, Orlando, FL.
56. Choong K, Menon K, Bohn D, et al.: Vasopressin in pediatric vasodilatory shock (VIP) study. ISRCTN-Current Controlled Trials registry, 11597444. Available at: http://www.controlled-trials.com/isrctn/trial/|/0/11597444.html. Accessed April 16, 2008.
57. Curley MA, Zimmerman JJ: Alternative outcome measures for pediatric clinical sepsis trials. Pediatr Crit Care Med 2005; 6:S150-S156.
58. Lindner KH, Dirks B, Strohmenger HU, et al.: Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996; 124: 1061-1064.
59. Morris DC, Dereczyk BE, Grzybowski M, et al.: Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997; 4:878-883.
60. Lindner KH, Dirks B, Strohmenger HU, et al.: Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997; 349: 535-537.
61. Stiell IG, Hebert PC, Wells GA, et al.: Vasopressin versus epinephrine for inhospital cardiac arrest: A randomised controlled trial. Lancet 2001; 358:105-109.
62. Lechner E, Hofer A, Mair R, et al.: Argininevasopressin in neonates with vasodilatory shock after cardiopulmonary bypass. Eur J Pediatr 2007; 166:1221-1227.
63. Meyer S, Gottschling S, Baghai A, et al.: Arginine- vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 2006; 10:R71 (doi: 10.1186/cc4917). (Pubitemid 47086854)
64. Meyer S, Loffler G, Polcher T, et al.: Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Acta Paediatr 2006; 95:1309-1312.
65. Masutani S, Senzaki H, Ishido H, et al.: Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int 2005; 47: 132-136.
66. Vasuvedan A, Lodha R, Kabra S: Vasopressin infusion in children with catecholamineresistant septic shock. Acta Paediatr 2005; 94:380-383.
67. Lechner E, Dickerson HA, Fraser CD Jr, et al.: Vasodilatory shock after surgery for aortic valve endocarditis: Use of low-dose vasopressin. Pediatr Cardiol 2004; 25:558-561.
68. Efrati O, Modan-Moses D, Vardi A, et al.: Intravenous arginine vasopressin in critically ill children: Is it beneficial? Shock 2004; 22: 213-217.
69. Leibovitch L, Efrati O, Vardi A, et al.: Intractable hypotension in septic shock: Successful treatment with vasopressin in an infant. Isr Med Assoc J 2003; 5:596-598.
70. Tobias JD: Arginine vasopressin for refractory distributive shock in two adolescents. J Intensive Care Med 2002; 17:48-52.
71. Liedel JL, Meadow W, Nachman J, et al.: Use of vasopressin in refractory hypotension in children with vasodilatory shock: Five cases and a review of the literature. Pediatr Crit Care Med 2002; 3:15-18.
72. Katz K, Lawler J, Wax J, et al.: Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation 2000; 47:33-40.
73. Papoff P, Mancuso M, Barbara CS, et al.: The role of terlipressin in pediatric septic shock: A review of the literature and personal experience. Int J Immunopathol Pharmacol 2007; 20:213-221.
74. Zeballos G, Lopez-Herce J, Fernandez C, et al.: Rescue therapy with terlipressin by continuous infusion in a child with catecholamine- resistant septic shock. Resuscitation 2006; 68:151-153.
75. Rodriguez-Nunez A, Lopez-Herce J, Gil- Anton J, et al.: Rescue treatment with terlipressin in children with refractory septic shock: A clinical study. Crit Care 2006; 10: R20 (doi:10.1186/cc3984). (Pubitemid 47079801)
76. Matok I, Vard A, Efrati O, et al.: Terlipressin as rescue therapy for intractable hypotension due to septic shock in children. Shock 2005; 23:305-310.
77. Peters MJ, Booth RA, Petros AJ: Terlipressin bolus induces systemic vasoconstriction in septic shock. Pediatr Crit Care Med 2004; 5:112-115.
78. Matok I, Leibovitch L, Vardi A, et al.: Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004; 5:116-118.
79. Wenzel V, Krismer AC, Arntz HR, et al.: A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350:105-113. (Pubitemid 38056221)
80. Kern KB, Halperin HR, Field J: New guidelines for cardiopulmonary resuscitation and emergency cardiac care: Changes in the management of cardiac arrest. JAMA 2001; 285:1267-1269.
81. American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: Part 7.2. Management of cardiac arrest. Circulation 2005; 112:IV-58 -IV-66.
82. Voelckel WG, Lurie KG, McKnite S, et al.: Comparison of epinephrine and vasopressin in a pediatric model of asphyxial cardiac arrest. Crit Care Med 2000; 28:3777-3783.
83. Voelckel WG, Lurie KG, McKnite S, et al.: Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med 2002; 30:957-962.
84. Mann K, Berg RA, Nadkarni V: Beneficial effects of vasopressin in prolonged pediatric cardiac arrest: A case series. Resuscitation 2002; 52:149-156.
85. Matok I, Vardi A, Augarten A, et al.: Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: A case series. Crit Care Med 2007; 35:1161-1164.
86. Duncan JM, Schexnayder S, Goel R, et al.: Vasopressin for in-hospital pediatric cardiac arrest: Results from the AHA national registry of CPR (NCPR):65. Crit Care Med 2005; 33:A17.
87. Holmes CL, Walley KR, Chittock DR, et al.: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27: 1416-1421.
88. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, et al.: Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 2004; 30:477-480.
89. Cartotto R, McGibney K, Smith T, et al.: Vasopressin for the septic burn patient. Burns 2007; 33:441-451.
90. Dünser MW, Mayr AJ, Tür A, et al.: Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamineresistant vasodilatory shock: Incidence and risk factors. Crit Care Med 2003; 31: 1394-1398.
91. van Haren FM, Rozendaal FW, van der Hoeven JG: The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003; 124: 2256-2260.
92. Luckner G, Dunser MW, Stadlbauer K-H, et al.: Cutaneous vascular reactivity and flow motion response to vasopressin in advanced vasodilatory shock and severe postoperative multiple organ dysfunction syndrome. Crit Care 2006; 10:R40 (doi:10.1186/cc4845). (Pubitemid 47079174)
93. Boerma EC, van der Voort PHJ, Ince C: Sublingual microcirculatory flow is impaired by the vasopressin-analogue terlipressin in a patient with catecholamine-resistant septic shock. Acta Anaesthesiol Scand 2005; 49: 1387-1390.
94. Parker MM: Pathophysiology of cardiovascular dysfunction in septic shock. New Horiz 1998; 6:130-138.